| __timestamp | Lantheus Holdings, Inc. | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13673000 | 45967000 |
| Thursday, January 1, 2015 | 14358000 | 114737000 |
| Friday, January 1, 2016 | 12203000 | 183204000 |
| Sunday, January 1, 2017 | 18125000 | 231644000 |
| Monday, January 1, 2018 | 17071000 | 293998000 |
| Tuesday, January 1, 2019 | 20018000 | 357355000 |
| Wednesday, January 1, 2020 | 32788000 | 412084000 |
| Friday, January 1, 2021 | 44966000 | 497153000 |
| Saturday, January 1, 2022 | 311681000 | 705789000 |
| Sunday, January 1, 2023 | 77707000 | 648449000 |
Infusing magic into the data realm
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Lantheus Holdings, Inc. and Ultragenyx Pharmaceutical Inc. have been at the forefront of this race. From 2014 to 2023, Ultragenyx consistently outpaced Lantheus in R&D investment, peaking in 2022 with a staggering 705% increase from its 2014 spending. In contrast, Lantheus saw a more modest growth, with a notable spike in 2022, reaching its highest R&D expenditure of the decade. This surge reflects a strategic pivot towards innovation, yet it still trails behind Ultragenyx's aggressive investment strategy. As the biotech landscape evolves, these spending patterns highlight the companies' commitment to pioneering new treatments and therapies, setting the stage for future breakthroughs.
R&D Spending Showdown: Amgen Inc. vs Lantheus Holdings, Inc.
Research and Development: Comparing Key Metrics for GSK plc and Ultragenyx Pharmaceutical Inc.
Research and Development: Comparing Key Metrics for Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc.
R&D Spending Showdown: BioMarin Pharmaceutical Inc. vs Ultragenyx Pharmaceutical Inc.
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Spending Showdown: Lantheus Holdings, Inc. vs MiMedx Group, Inc.
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs MorphoSys AG
Who Prioritizes Innovation? R&D Spending Compared for Ultragenyx Pharmaceutical Inc. and MannKind Corporation
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs Viridian Therapeutics, Inc.